Multiparametric MRI assessment of response to convection-enhanced intratumoral delivery of MDNA55, an interleukin-4 receptor targeted immunotherapy, for recurrent glioblastoma

por Mohan, Suyash, Wang, Sumei, Chawla, Sanjeev, Abdullah, Kalil, Desai, Arati, Maloney, Eileen, Brem, Steven
Publicado 2021

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

por BAUMAN, JESSICA, LANGER, COREY, QUON, HARRY, ALGAZY, KENNETH, LIN, ALEXANDER, DESAI, ARATI, MUTALE, FAITH, WEISS, JARED
Publicado 2013

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features

por Nasrallah, Mac Lean P., Desai, Arati, O’Rourke, Donald M., Surrey, Lea F., Stein, Joel M.
Publicado 2020

2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma

por Schwab, Robert D., Bagley, Stephen, Binder, Zev, Lustig, Robert, O’Rourke, Donald, Brem, Steven, Desai, Arati S., Nasrallah, MacLean
Publicado 2018

Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients

por Koch, Cameron J., Lustig, Robert A., Yang, Xiang-Yang, Jenkins, Walter T., Wolf, Ronald L., Martinez-Lage, Maria, Desai, Arati, Williams, Dewight, Evans, Sydney M.
Publicado 2014

BIMG-12. [18F]FLUCICLOVINE PET TO DISTINGUISH PSEUDOPROGRESSION FROM TUMOR PROGRESSION IN POST-TREATMENT GLIOBLASTOMA

por Nabavizadeh, Ali, Doot, Robert, Young, Anthony, Nasrallah, MacLean, Ware, Jeffrey, Schubert, Erin, Henderson, Fraser, Pantel, Austin, Desai, Arati, Bagley, Stephen, O’Rourke, Donald, Brem, Steven
Publicado 2021

Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI

por de Godoy, Laiz Laura, Lim, Kheng Choon, Rajan, Archith, Verma, Gaurav, Hanaoka, Mauro, O’Rourke, Donald M., Lee, John Y. K., Desai, Arati, Chawla, Sanjeev, Mohan, Suyash
Publicado 2023

Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas

por de Godoy, Laiz Laura, Mohan, Suyash, Wang, Sumei, Nasrallah, MacLean P., Sakai, Yu, O’Rourke, Donald M., Bagley, Stephen, Desai, Arati, Loevner, Laurie A., Poptani, Harish, Chawla, Sanjeev
Publicado 2023

Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma

por Verma, Gaurav, Chawla, Sanjeev, Mohan, Suyash, Wang, Sumei, Nasrallah, MacLean, Sheriff, Sulaiman, Desai, Arati, Brem, Steven, O'Rourke, Donald M., Wolf, Ronald L., Maudsley, Andrew A., Poptani, Harish
Publicado 2018

(18)F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling

por Henderson, Fraser, Brem, Steven, O’Rourke, Donald M, Nasrallah, MacLean, Buch, Vivek P, Young, Anthony J, Doot, Robert K, Pantel, Austin, Desai, Arati, Bagley, Stephen J, Nabavizadeh, S Ali
Publicado 2020

Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma

por Wang, Sumei, O’Rourke, Donald M., Chawla, Sanjeev, Verma, Gaurav, Nasrallah, MacLean P., Morrissette, Jennifer J. D., Plesa, Gabriela, June, Carl H., Brem, Steven, Maloney, Eileen, Desai, Arati, Wolf, Ronald L., Poptani, Harish, Mohan, Suyash
Publicado 2018

Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma

por Nabavizadeh, S. Ali, Akbari, Hamed, Ware, Jeffrey B., Nasrallah, MacLean, Guiry, Samantha, Bagley, Stephen J., Desai, Arati, Levy, Scott, Sarchiapone, Whitney, Prior, Timothy, Detre, John, Wolf, Ronald L., O’Rourke, Donald M., Brem, Steven, Davatzikos, Christos
Publicado 2019

Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma

por Bagley, Stephen J, Till, Jacob, Abdalla, Aseel, Sangha, Hareena K, Yee, Stephanie S, Freedman, Jake, Black, Taylor A, Hussain, Jasmin, Binder, Zev A, Brem, Steven, Desai, Arati S, O’Rourke, Donald M, Long, Qi, Nabavizadeh, Seyed Ali, Carpenter, Erica L
Publicado 2021

Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging

por Akbari, Hamed, Kazerooni, Anahita Fathi, Ware, Jeffrey B., Mamourian, Elizabeth, Anderson, Hannah, Guiry, Samantha, Sako, Chiharu, Raymond, Catalina, Yao, Jingwen, Brem, Steven, O’Rourke, Donald M., Desai, Arati S., Bagley, Stephen J., Ellingson, Benjamin M., Davatzikos, Christos, Nabavizadeh, Ali
Publicado 2021

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma

por Nasrallah, MacLean P., Binder, Zev A., Oldridge, Derek A., Zhao, Jianhua, Lieberman, David B., Roth, Jacquelyn J., Watt, Christopher D., Sukhadia, Shrey, Klinman, Eva, Daber, Robert D., Desai, Arati, Brem, Steven, O’Rourke, Donald M., Morrissette, Jennifer J. D.
Publicado 2019

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma

por Makhlin, Igor, Salinas, Ryan D, Zhang, Daniel, Jacob, Fadi, Ming, Gou-li, Song, Hongjun, Saxena, Deeksha, Dorsey, Jay F, Nasrallah, MacLean P, Morrissette, Jennifer JD, Binder, Zev A, O'Rourke, Donald M, Desai, Arati S, Brem, Steven, Bagley, Stephen J
Publicado 2019

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma

por Durgin, Joseph S., Henderson, Fraser, Nasrallah, MacLean P., Mohan, Suyash, Wang, Sumei, Lacey, Simon F., Melenhorst, Jan Joseph, Desai, Arati S., Lee, John Y. K., Maus, Marcela V., June, Carl H., Brem, Steven, O’Connor, Roddy S., Binder, Zev, O’Rourke, Donald M.
Publicado 2021

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma

por Nabavizadeh, Seyed Ali, Ware, Jeffrey B, Guiry, Samantha, Nasrallah, MacLean P, Mays, Jazmine J, Till, Jacob E, Hussain, Jasmin, Abdalla, Aseel, Yee, Stephanie S, Binder, Zev A, O’Rourke, Donald M, Brem, Steven, Desai, Arati S, Wolf, Ronald, Carpenter, Erica L, Bagley, Stephen J
Publicado 2020

Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma

por Fathi Kazerooni, Anahita, Saxena, Sanjay, Toorens, Erik, Tu, Danni, Bashyam, Vishnu, Akbari, Hamed, Mamourian, Elizabeth, Sako, Chiharu, Koumenis, Costas, Verginadis, Ioannis, Verma, Ragini, Shinohara, Russell T., Desai, Arati S., Lustig, Robert A., Brem, Steven, Mohan, Suyash, Bagley, Stephen J., Ganguly, Tapan, O’Rourke, Donald M., Bakas, Spyridon, Nasrallah, MacLean P., Davatzikos, Christos
Publicado 2022

The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics

por Bakas, Spyridon, Sako, Chiharu, Akbari, Hamed, Bilello, Michel, Sotiras, Aristeidis, Shukla, Gaurav, Rudie, Jeffrey D., Santamaría, Natali Flores, Kazerooni, Anahita Fathi, Pati, Sarthak, Rathore, Saima, Mamourian, Elizabeth, Ha, Sung Min, Parker, William, Doshi, Jimit, Baid, Ujjwal, Bergman, Mark, Binder, Zev A., Verma, Ragini, Lustig, Robert A., Desai, Arati S., Bagley, Stephen J., Mourelatos, Zissimos, Morrissette, Jennifer, Watt, Christopher D., Brem, Steven, Wolf, Ronald L., Melhem, Elias R., Nasrallah, MacLean P., Mohan, Suyash, O’Rourke, Donald M., Davatzikos, Christos
Publicado 2022